On October 3, 2024, Abivax S.A. issued a press release regarding company updates, filed under SEC Form 6-K, indicating it will file annual reports under Form 20-F. The filing is of significant importance for the company and falls under the category of 'Other Special Situation', with a neutral sentiment from an equity investor perspective.